EBV BMLF-1 280-288 (HLA-A*02:01) GLCTLVAML
Sipariş numarası: P2295.9501
Shipping: Shipment: not cooled. Store at -20°C. For laboratory usage only!Teslim süresi yaklaşık. 5 iş günü
Miktar | Birim fiyatı |
---|---|
Hedef 2 | 145,00 € * |
Kaynak 3 | 116,00 € * |
Fiyatlar artı KDV artı nakliye maliyetleri
Single peptide (GLCTLVAML) for stimulation of humanEBV BMLF-1(280-288) CD8+ specific CD8+ T-cells.
The peptide is synthesised as it is presented by the MHC class I HLA-A*0201 allele. Purities offered: >95%.
T-cell epitopes are presented on the surface of antigen-presenting cells by MHC molecules. T- cell epitopes presented by MHC class I molecules are typically peptides between 8 and 11 amino acids in length and exhibiting MHC-specific sequence motifs.
Technische Daten:
Specifications:
Purity: >95% (HPLC, ESi-MS)
Sequence: GLCTLVAML
HLA-type: HLA-A*02:01
lyophilized powder
Applikation:
control peptide for stimulation of IFN gamma release from CD8+ T cellsQuelle
syntheticSicherheits Hinweise / Safety
Klassifizierungen / Classification
eclass-Nr: 32-16-04-09Dokumente - Protokolle - Downloads
Hier finden Sie Informationen und weiterführende Literatur zu EBV BMLF-1 280-288 (HLA-A*02:01) GLCTLVAML. Für weitere Dokumente (Zertifikate mit weiteren Lotnummern, Sicherheitsdatenblätter in anderer Sprache, weitere Produktinformationen) wenden Sie sich bitte an Genaxxon biosience unter: info@genaxxon.com oder Tel.: +49 731 3608 123.